Robin Wolz

Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC.

Part of Tripos, Inc., Receptor Research Ltd. provides drug discovery informatics products and services. The company is based in Bude, UK. Receptor Research was acquired by Tripos, Inc. on November 18, 1997.

The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.

MDX Medical, Inc. provides online doctor evaluation and comparison services. It offers health plans, employers vitalsmartshopper and consumer media kit. The company was founded by Mitchel E. Rothschild, Richard D. Forman and Todd K. Rosengart in 2006 and is headquartered in Lyndhurst, NJ.

Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom.

Laboratoire Glaxosmithkline SAS manufactures pharmaceutical products. The company was founded in 2001 and is headquartered in Rueil-Malmaison, France.

Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom.

The Royal Humane Society operates as charity that grants awards for acts of bravery in the saving of human life and also for the restoration of life by resuscitation. The company was founded by William Hawes and Thomas Cogan in 1774 and is headquartered in London, the United Kingdom.

Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom.

UK Biobank Ltd. is a biomedical database and research resource that contains genetic, lifestyle, and health information from half a million participants aged between 40-69 years in 2006-2010 from across the UK. The organization has over 220 dedicated members of staff, based in multiple locations across the UK. UK Biobank's research resource is a major contributor to the advancement of modern medicine and treatment, enabling better understanding of the prevention, diagnosis, and treatment of a wide range of serious and life-threatening illnesses, including cancer, heart diseases, and stroke. The non-profit company is based in Stockport, UK, and has subsidiaries in the United Kingdom. The database includes blood samples, heart and brain scans, and genetic data that are accessible to approved researchers who are undertaking health-related research that is in the public interest. The CEO of the British company is Rory Collins.

Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom.

Creo Medical Ltd. develops, manufactures and commercializes medical device technologies. It offers CROMA system, an electrosurgical unit that delivers bipolar radiofrequency power for the purpose of cutting, and microwave power for the purpose of coagulating tissue to staunch bleeding vessels. The firm also offers RS2 instrument, a retractable injection needle for tissue lift and irrigation. The company was founded by Christopher Paul Hancock and Steven Morris in 2003 and is headquartered in Chepstow, the United Kingdom.

Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford.

Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

Buckinghamshire Healthcare NHS Trust is a healthcare organization that prioritizes the well-being of its patients. The non-profit company is based in Amersham, UK. The British company provides safe and compassionate care to their patients, ensuring that their needs are met every time.

Syncona Investment Management Ltd. (Syncona) is the asset management subsidiary of Syncona Ltd. in Great Britain. Headquartered in London, the firm was co-founded by Martin Murphy alongside The Wellcome Trust. Syncona is focused on founding, building and funding a portfolio of global leaders in life science.

Part of Ixico Plc, IXICO Technologies Ltd. is a British company that provides data analytics services to the biopharmaceutical industry. The company is based in London, UK and was founded in 2004.

Part of Syncona Ltd., Syncona Discovery Ltd. is a British company that provides investment services. The company is based in London, UK. Syncona Discovery was founded in 2013.

Korn Wall Ltd. is a British company that operates a distribution network with partners across various locations, including the Pacific. Korn Wall is based in Cardiff, UK. The private company is world leaders in privacy screen innovation and offer products that are more hygienic, sustainable, and cost-effective than traditional hospital curtains. The company's mission is to replace disposable curtains while also brightening healthcare spaces with art.

Science Creates Ventures LLP (Science Creates Ventures) is a venture capital firm founded in 2020 by Harry Destecroix and Jonathan Craton. The firm is headquartered in Bristol, United Kingdom.

Angelini Ventures SpA (Angelini Ventures) is a venture capital firm founded in 2022. The firm is headquartered in Rome, Italy.

Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom.

Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991.